Fibromyalgia syndrome is a common and chronic disorder characterised by widespread muscle pain, fatigue, and multiple tender points. The word fibromyalgia comes from the Latin term for fibrous tissue (fibro) and the Greek ones for muscle (myo) and pain (algia). This book presents the research in this field.

Called the “invisible disease,” fibromyalgia is estimated to impact more than 10 million Americans. And yet, so much is still misunderstood about this chronic disorder. Mayo Clinic Guide to Fibromyalgia is an invaluable resource for understanding fibromyalgia and its debilitating symptoms. Those living with fibromyalgia know it is an invasive disorder, one that can cause overwhelming fatigue, joint stiffness, sleep problems, migraines, digestive problems, and troubles with memory and concentration, a symptom so common it is often referred to as “fibrofog.” While it's believed that humans have suffered from fibromyalgia for hundreds, even thousands, of years, a delay in medical research means many people living with fibromyalgia are still in the dark, confused by their symptoms and what causes the painful disorder. By drawing upon decades of advanced research in studying and treating fibromyalgia, Mayo Clinic Guide to Fibromyalgia combines anecdotes from real cases with expertise from Mayo Clinic’s rheumatology and chronic pain experts to provide an all-encompassing guide for understanding one of the most common chronic illnesses affecting Americans today. This book also offers reasonable, proven strategies—like worksheets to help readers craft a personalized daily plan—for managing common fibromyalgia symptoms, while serving as a comforting guide for those who may feel alone in their journey with fibromyalgia. This book breaks down what fibromyalgia is—and isn’t—in 4 separate sections: · Section 1 introduces fibromyalgia, the history and modern discoveries of fibromyalgia research, as well as common myths and misconceptions associated with the condition · Section 2 outlines the different treatment options available to those who suffer from fibromyalgia, including prescription medications, therapies, and forms of integrative medicine · Section 3 offers helpful tips for managing—and improving—chronic pain through diet, exercise, sleep, and stress management · Finally, Section 4 explains how to find guidance and support from your family, friends, and physicians to help you live a life unhindered by fibromyalgia If you’re struggling to advance past your painful fibromyalgia symptoms, get the book Publisher’s Weekly described as “the first [book] a newly diagnosed patient should consult.”

Eight simple and relaxing yoga sequences for fibromyalgia patients looking to manage their pain, alleviate their fatigue, and improve their overall well-being Fibromyalgia is characterized by widespread pain in muscles, ligaments, and tendons, as well as fatigue and multiple tender points (places on the body where slight pressure causes pain). Although mainstream medicine has yet to devise a successful plan for treating fibromyalgia, yoga offers sensible strategies for managing—and sometimes overcoming—the pain. Written by a yoga teacher and suitable for both yoga novices and veterans, this book is grounded in simple movements, breathing techniques, and guided visualization and relaxation sessions. Readers learn to reduce stress and manage fibromyalgia through eight sequences: four for pain relief, one to diminish fatigue and improve sleep, and three for maintaining body awareness and general flexibility. The author’s simple, supportive language and mixture of theory, practice, and the latest scientific data offer hope for one of today's most challenging health conditions.

Myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) are serious, debilitating conditions that affect millions of people in the United States and around the world. ME/CFS can cause significant impairment and disability. Despite substantial efforts by researchers to better understand ME/CFS, there is no known cause or effective treatment. Diagnosing the disease remains a challenge, and patients often struggle with their illness for years before an identification is made. Some health care providers have been skeptical about the serious physiological - rather than psychological - nature of the illness. Once diagnosed, patients often complain of receiving hostility from their health care provider as well as being subjected to treatment strategies that exacerbate their symptoms. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome proposes new diagnostic clinical criteria for ME/CFS and a new term for the illness - systemic exertion intolerance disease(SEID). According to this report, the term myalgic encephalomyelitis does not accurately describe this illness, and the term chronic fatigue syndrome can result in trivialization and stigmatization for patients afflicted with this illness. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome stresses that SEID is a medical - not a psychiatric or psychological - illness. This report lists the major symptoms of SEID and recommends a diagnostic process.One of the report's most important conclusions is that a thorough history, physical examination, and targeted work-up are necessary and often sufficient for diagnosis. The new criteria will allow a large percentage of undiagnosed patients to receive an accurate diagnosis and appropriate care. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome will be a valuable resource to promote the prompt diagnosis of patients with this complex, multisystem, and often devastating disorder; enhance public understanding; and provide a firm foundation for future improvements in diagnosis and treatment.

Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life. Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia. Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and challenging nature of treating fibromyalgia and comorbid disorders, it is imperative to educate primary care providers on the initial symptons, complications, and treatment strategies for fibromyalgia, as most patients with the condition will see a primary care provider for initial diagnosis/referral, and follow-up-care. In the years since the release of the ACR criteria, increasing recognition and advances in research have provided key insights into the etiology of fibromyalgia, resulting in the use of several successful pharmacological, as well as non-pharmacological, treatment approaches. However, despite the efforts of professional medical organizations and patient care groups, awareness of the current state of clinical assessment and treatment of fibromyalgia by healthcare professionals continues to be lacking. This book is designed to provide a succint and practical guide to help primary care physicians, internists, specialists, and allied health professionals effectively diagnose and manage patients with fibromyalgia. This concise volume will provide an essential understanding of the pathophysiology of the pain, subtypes, and pitfalls in the diagnosis of this chronic condition.

This volume is the first comprehensive text devoted to fibromyalgia and other centrally mediated chronic pain syndromes. Leading experts examine the latest research findings on these syndromes and present evidence-based reviews of current controversies. Chapters discuss the definition, epidemiology, and pathophysiology of chronic pain and fibromyalgia, the clinical presentations of fibromyalgia syndrome, and central sensitization syndromes associated with chronic neuromuscular pain. The contributors thoroughly examine various approaches to evaluation and management of patients with fibromyalgia and chronic pain. Other chapters focus on disability issues, prognosis, and future research directions. A critically reviewed listing of Websites and other resources is included.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

This volume represents edited material that was presented at a conference on brainstem modulation of spinal nociception held in Beaune, France during July, 1987. Pain Modulation, Volume 77 in the series Progress in Brain Research reviews, analyses and suggests new research strategies on several relevant topics including: the endogenous opioid peptides; sites of action of opiates; the role of biogenic animes and non-opioid peptides in analgesia; dorsal horn circuitry; behavioural factors in the activation of pain modulating networks and clinical studies of nociceptive modulation.

Presenting practical suggestions for relief of pain based on the results of a research study of metabolism, this book offers hope to fibromyalgia sufferers through suggestions of simple lifestyle changes. Since the specific cause of chronic pain associated with fibromyalgia has not yet been explained, this analysis looks at various metabolic imbalances that often produce pain, methods used for diagnosing fibromyalgia, other symptoms that are associated with chronic pain, and the effects of environmental stress on metabolism. Explanations of how daily nutritional choices affect metabolic health are included, and nutritional supplements and natural health techniques such as homeopathy, exercise, and bodywork are provided.